Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and parkinson's disease brain

Journal of Neurochemistry

Volumn 107, Issue 5, 2008, Pages 1398-1413

  DeCuypere, Michael ^a   Lu, Yan ^a   Miller, Duane D ^a   LeDoux, Mark S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

N methyl salsolinol; Parkinson's disease; Salsolinol; Substantia nigra pars compacta; Tetrahydroisoquinoline

Indexed keywords

BENZYL DERIVATIVE; DOPAMINE; METHYL GROUP; N METHYLSALSOLINOL; SALSOLINOL; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOSYNTHESIS; BRAIN REGION; CATECHOLAMINE NERVE CELL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; ELECTROCHEMICAL DETECTION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MESENCEPHALON; MONOAMINE NERVE CELL; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TISSUE LEVEL;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DOPAMINE; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY; TETRAHYDROISOQUINOLINES;

RATTUS; RODENTIA;

EID: 55849092577     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05709.x     Document Type: Article

References (65)

1. Akao Y., Nakagawa Y., Maruyama W., Takahashi R. Naoi M. (1999) Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3. Neurosci. Lett. 267, 153 156.
2. Axelrod J., Kopin I. J. Mann J. D. (1959) 3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine. Biochim. Biophys. Acta 36, 576 577.
3. Bail M., Miller S. Cohen G. (1980) Selective 7-O-methylation of salsolinol in rat brain and heart in vivo. Life Sci. 26, 2051 2060.
4. Ballard P. A., Tetrud J. W. Langston J. W. (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35, 949 956.
5. Bembenek M. E., Abell C. W., Chrisey L. A., Rozwadowska M. D., Gessner W. Brossi A. (1990) Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines. J. Med. Chem. 33, 147 152.
6. Cohen G. Collins M. (1970) Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism. Science 167, 1749 1751.
7. Collins M. A. Origitano T. C. (1983) Catecholamine-derived tetrahydroisoquinolines: O-methylation patterns and regional brain distribution following intraventricular administration in rats. J. Neurochem. 41, 1569 1575.
8. Collins A. C., Cashaw J. L. Davis V. E. (1973) Dopamine-derived tetrahydroisoquinoline alkaloids - inhibitors of neuroamine metabolism. Biochem. Pharmacol. 22, 2237 2248.
9. Collins M. A., Ung-Chhun N., Cheng B. Y. Pronger D. (1990) Brain and plasma tetrahydroisoquinolines in rats: effects of chronic ethanol intake and diet. J. Neurochem. 55, 1507 1514.
10. Den Hartog Jager W. A. Bethlem J. (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J. Neurol. Neurosurg. Psychiatry 23, 283 290.
11. Deng Y., Maruyama Y., Kawai M., Dostert P., Yamamura H., Takahashi T. Naoi M. (1997) Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive. J. Chromatogr. B Biomed. Sci. Appl. 689, 313 320.
12. Dostert P., Strolin Benedetti M., Dordain G. Vernay D. (1989) Enantiomeric composition of urinary salsolinol in parkinsonian patients after Madopar. J. Neural Transm. Park. Dis. Dement. Sect. 1, 269 278.
13. Duncan M. W. Smythe G. A. (1982) Salsolinol and dopamine in alcoholic beverages. Lancet 1, 904 905.
14. Duncan M. W., Smythe G. A., Nicholson M. V. Clezy P. S. (1984) Comparison of high-performance liquid chromatography with electrochemical detection and gas chromatography-mass fragmentography for the assay of salsolinol, dopamine and dopamine metabolites in food and beverage samples. J. Chromatogr. 336, 199 209.
15. Fratiglioni L. Wang H. X. (2000) Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav. Brain Res. 113, 117 120.
16. Hirsch E. C. Faucheux B. A. (1998) Iron metabolism and Parkinson's disease. Mov. Disord. 13 (Suppl. 1 39 45.
17. Holm S. (1979) A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65 70.
18. Kohno M., Ohta S. Hirobe M. (1986) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem. Biophys. Res. Commun. 140, 448 454.
19. Konradi C., Kornhuber J., Sofic E., Heckers S., Riederer P. Beckmann H. (1992) Variations of monoamines and their metabolites in the human brain putamen. Brain Res. 579, 285 290.
20. Kotake Y., Tasaki Y., Makino Y., Ohta S. Hirobe M. (1995) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J. Neurochem. 65, 2633 2638.
21. Langston J. W., Ballard P., Tetrud J. W. Irwin I. (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979 980.
22. Levy G., Khanna N. N., Soda D. M., Tsuzuki O. Stern L. (1975) Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics. 55, 818 825.
23. Makino Y., Ohta S., Tachikawa O. Hirobe M. (1988) Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson's disease. Life Sci. 43, 373 378.
24. Martin H. F. Gudzinowicz B. J. (1963) Thermal stability of polynuclear aromatic hydrocarbons and the polarographic half-wave reduction potential. Nature 200, 69 70.
25. Maruyama W., Strolin-Benedetti M., Takahashi T. Naoi M. (1997a) A neurotoxin N-methyl(R)salsolinol induced apoptotic cell death in differentiated human dopaminergic neuroblastoma SH-SY5Y cells. Neurosci. Lett. 232, 147 150.
26. Maruyama W., Sobue G., Matsubara K., Hashizume Y., Dostert P. Naoi M. (1997b) A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain. Neurosci. Lett. 223, 61 64.
27. Maruyama W., Abe T., Tohgi H. Naoi M. (1999) An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease. Neurosci. Lett. 262, 13 16.
28. Maruyama W., Boulton A. A., Davis B. A., Dostert P. Naoi M. (2001) Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine. J Neural Transm. 108, 11 24.
29. McNaught K. S., Thull U., Carrupt P. A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P. Marsden C. D. (1995) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Biochem. Pharmacol. 50, 1903 1911.
30. Meyerson L. R., McMurtrey K. D. Davis V. E. (1976) Neuroamine-derived alkaloids: substrate-preferred inhibitors of rat brain monoamine oxidase in vitro. Biochem. Pharmacol. 25, 1013 1020.
31. Minami M., Maruyama W., Dostert P., Nagatsu T. Naoi M. (1993) Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4- tetrahydroisoquinolines and their N-methylated derivatives. J. Neural Transm. Gen. Sect. 92, 125 135.
32. Moser A. Kömpf D. (1992) Presence of methyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF. Life Sci. 50, 1885 1891.
33. Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Wittig H. Madea B. (1999) A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas. Forensic Sci. Int. 105, 1 11.
34. Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Jachau K. Madea B. (2000) Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry. Forensic Sci. Int. 113, 359 366.
35. Musshoff F., Lachenmeier D. W., Kroener L., Schmidt P., Dettmeyer R. Madea B. (2003) Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective. Cell Mol Biol (Noisy-le-grand). 49, 837 849.
36. Musshoff F., Lachenmeier D. W., Schmidt P., Dettmeyer R. Madea B. (2005) Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. Alcohol. Clin. Exp. Res. 29, 46 52.
37. Naoi M., Maruyama W., Matsubara K. Hashizume Y. (1997) A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains. Neurosci. Lett. 235, 81 84.
38. Naoi M., Maruyama W., Akao Y., Zhang J. Parvez H. (2000) Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons. Toxicology. 153, 123 141.
39. Naoi M., Maruyama W., Akao Y. Yi H. (2002) Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Neurotoxicol. Teratol. 24, 579 591.
40. Naoi M., Maruyama W. Nagy G. M. (2004) Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology. 25, 193 204.
41. Niwa T., Takeda N., Kaneda N., Hashizume Y. Nagatsu T. (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem. Biophys. Res. Commun. 144, 1084 1089.
42. Niwa T., Yoshizumi H., Tatematsu A., Matsuura S. Nagatsu T. (1989) Presence of tetrahydroisoquinoline, a parkinsonism related compound, in foods. J. Chromatogr. 493, 345 352.
43. Niwa T., Takeda N., Yoshizumi H., Tatematsu A., Yoshida M., Dostert P., Naoi M. Nagatsu T. (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline, novel endogenous amines, in parkinsonism and normal human brains. Biochem Biophys Res Comm. 177, 603 609.
44. Ogawa M., Araki M., Nagatsu I., Nagatsu T. Yoshida M. (1989) The effect of 1,2,3,4-tetrahydroisoquinoline (TIQ) on mesencephalic dopaminergic neurons in C57BL/6J mice: immunohistochemical studies-tyrosine hydroxylase. Biogenic Amines. 6, 427 436.
45. Origitano T. C. Collins M. A. (1980) Confirmation of an unexpected brain O-methylation pattern for the dopamine-derived tetrahydroisoquinoline, salsolinol. Life Sci. 26, 2061 2065.
46. Pacifici G. M., Temellini A., Castiglioni M., D'Alessandro C., Ducci A. Giuliani L. (1994) Interindividual variability of the human hepatic sulphotransferases. Chem. Biol. Interact. 92, 219 231.
47. Richter D. (1940) The inactivation of adrenaline in vivo in man. J. Physiol. 98, 361 374.
48. Riggin R. M. Kissinger P. T. (1976) Letter: identification of salsolinol as a phenolic component in powdered cocoa and cocoa-based products. J. Agric. Food. Chem. 24, 900.
49. Riggin R. M., McCarthy M. J. Kissinger P. T. (1976) Identification of salsolinol as a major metabolite in the banana. J. Agric. Food. Chem. 24, 189 191.
50. Rommelspacher H. Susilo R. (1985) Tetrahydroisoquinolines and beta-carbolines: putative natural substances in plants and mammals. Prog. Drug Res. 29, 415 459.
51. Sasaoka T., Kaneda N., Niwa T., Hashizume Y. Nagatsu T. (1988) Analysis of salsolinol in human brain using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 428, 152 155.
52. Schapira A. H. (2001) Causes of neuronal death in Parkinson's disease. Adv. Neurol. 86, 155 162.
53. Schöpf C. Bayerle H. (1934) Zur frage der biogenese der isochinolin-alkaloide. Ann Chem. 513, 190 202.
54. Shavali S. Ebadi M. (2003) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis. Neurotoxicology 24, 417 424.
55. Sjöquist B., Eriksson A. Winblad B. (1982a) Brain salsolinol levels in alcoholism. Lancet 1, 675 676.
56. Sjöquist B., Eriksson A. Winblad B. (1982b) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog. Clin. Biol. Res. 90, 57 67.
57. Song Y., Xu J., Hamme A. Liu Y. (2006) Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier. J. Chromatogr. A 1103, 229 234.
58. Storch A., Kaftan A., Burkhardt K. Schwarz J. (2000) 1-Methyl-6,7- dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855, 67 75.
59. Tasaki Y., Makino Y., Ohta S. Hirobe M. (1991) 1-Methyl-1,2,3,4- tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem. 57, 1940 1943.
60. Thull U., Kneubühler S., Gaillard P., Carrupt P. A., Testa B., Altomare C., Carotti A., Jenner P. McNaught K. S. (1995) Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships. Biochem. Pharmacol. 50, 869 877.
61. Thumen A., Behnecke A., Fatimunnisa Q., Englbert B. Moser A. (2002) N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo. Neuroreport. 13, 25 28.
62. Tóth B. E., Homicskó K., Radnai B. et al. (2001) Salsolinol is a putative endogenous neuro-intermediate lobe prolactin-releasing factor. J. Neuroendocrinol. 13, 1042 1050.
63. Wang W., Ameno K., Jamal M., Kumihashi M., Uekita I., Ameno S. Ijiri I. (2007) Effect of direct infusion of acetaldehyde on dopamine and dopamine-derived salsolinol in the striatum of free-moving rats using a reverse microdialysis technique. Arch. Toxicol. 81, 121 126.
64. Yamada Y. (1971) Effects of salsolinol on rat brain and liver monoamine oxidase. Jpn. J. Pharmacol. 21, 833 835.
65. Young W. F., Okazaki H., Laws E. R. Weinshilboum R. M. (1984) Human brain phenol sulfotransferase: biochemical properties and regional localization. J. Neurochem. 43, 706 715.